On November 1, 2022, Novavax, Inc. filed a Current Report on Form 8-K reporting that the company's board of directors had appointed Richard J. Rodgers to the Board. At the time of the filing, the Board had not determined on which Board committees Mr. Rodgers would serve, and this Form 8-K/A is being filed for the purpose of reporting his committee appointments approved by the Board. On December 8, 2022, the board appointed Mr. Rodgers as a member of its Audit Committee and as a member of its Compensation Committee, each appointment effective immediately.